{
    "nct_id": "NCT04005339",
    "official_title": "NAPOLI-2: Phase II Study of Fluorouracil, Leucovorin, and Nanoliposomal Irinotecan in Previously Treated Advanced Biliary Tract Cancer",
    "inclusion_criteria": "* Pathologically-confirmed biliary tract cancer (cholangiocarcinoma or gallbladder adenocarcinoma), unresectable or metastatic\n* Disease progression on or intolerance of gemcitabine- and platinum-based chemotherapy\n* No more than 1 prior line of chemotherapy for unresectable or metastatic disease (adjuvant therapy does not count)\n* Measurable disease by RECIST v1.1 criteria\n* ECOG performance status of 0-1\n* At least 18 years of age\n* HIV-positive patients are eligible provided: Stable HAART regimen, No concurrent prophylactic antibiotics or antifungals, and CD4 count above 250 and undetectable viral load\n* Adequate bone marrow, hepatic, and renal function\n* Consent to access archived tumor tissue if available (available tissue is not required for enrollment)\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Ampullary adenocarcinoma\n* Woman who are pregnant or breastfeeding\n* Anti-cancer treatment within 3 weeks prior to enrollment\n* Prior irinotecan or nanoliposomal irinotecan\n* Central nervous system metastases unless stable for at least 4 weeks and at least 2 weeks off corticosteroids\n* Exposure to a strong CYP3A4 inducer, strong CYP3A4 inhibitor, or strong UGT1A1 inhibitor within 2 weeks of study start\n* Known concurrent malignancy or other malignancy within 3 years except for non-melanomatous skin cancers, prostate or cervical cancers following curative therapy, or superficial bladder cancer\n* Bowel obstruction\n* Allergy or hypersensitivity to fluoropyrimidines, irinotecan, or nanoliposomal irinotecan\n* Clinically significant liver disease: Patients with resolved hepatitis B infection are eligible if HBsAg testing is negative; Patients with resolved hepatitis C infection are eligible if viral RNA PCR is negative\n* Severe infections within 4 weeks prior to enrollment\n* Major surgery within 4 weeks prior to enrollment",
    "miscellaneous_criteria": ""
}